Drug Type Small molecule drug |
Synonyms MSHrelease inhibiting factor |
Target |
Action antagonists |
Mechanism MC1R antagonists(Melanocortin receptor 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H24N4O3 |
InChIKeyNOOJLZTTWSNHOX-UWVGGRQHSA-N |
CAS Registry2002-44-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Phase 2 | United States | - |